REGENXBIO Announces New Gene Therapy Program for Duchenne Muscular Dystrophy
PPMD is incredibly excited to share REGENXBIO’s announcement of their new program for Duchenne muscular dystrophy. REGENXBIO is seeking to treat Duchenne through a gene therapy approach delivering a novel microdystrophin transgene. Their gene therapy…Learn More
